González-Moles MÁ, de Porras-Carrique T, Ramos-García P. Association of oral lichen planus with hepatic disorders and hepatocellular carcinoma: systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2023 May 1;28 (3):e229-37.
doi:10.4317/medoral.25661
https://dx.doi.org/doi:10.4317/medoral.25661
1. Carrozzo M, Porter S, Mercadante V, Fedele S. Oral lichen planus: A disease or a spectrum of tissue reactions? Types, causes, diagnostic algorhythms, prognosis, management strategies. Periodontol 2000. 2019;80:105-25. |
PMid:31090143 |
2. González-Moles MÁ, Warnakulasuriya S, González-Ruiz I, González-Ruiz L, Ayén Á, Lenouvel D, et al. Worldwide prevalence of oral lichen planus: A systematic review and meta-analysis. Oral Dis. 2021;27:813-28. |
PMid:32144836 |
3. De Porras-Carrique T, González-Moles MÁ, Warnakulasuriya S, Ramos-García P. Depression, anxiety, and stress in oral lichen planus: a systematic review and meta-analysis. Clin Oral Investig. 2022;26:1391-408. |
PMid:34460001 PMCid:PMC8816610 |
4. De Porras-Carrique T, Ramos-García P, Aguilar-Diosdado M, Warnakulasuriya S, Ángel González-Moles M. Autoimmune disorders in oral lichen planus: systematic review and meta-analysis. Oral Dis. 2022. |
PMid:35000260 |
5. Lauritano D, Arrica M, Lucchese A, Valente M, Pannone G, Lajolo C, et al. Oral lichen planus clinical characteristics in Italian patients: a retrospective analysis. Head Face Med. 2016;12:18. |
PMid:27113338 PMCid:PMC4845340 |
6. Pitak-Arnnop P, Subbalekha K, Sirintawat N, Tangmanee C, Auychai P, Muangchan C, et al. Are oral lichen planus patients at high risk of hepatitis C? A case-control study. J Stomatol oral Maxillofac Surg. 2021;123:e37-e42. |
PMid:34332181 |
7. del Olmo JA, Pascual I, Bagan J V, Serra MA, Escudero A, Rodriguez F, et al. Prevalence of hepatitis C virus in patients with lichen planus of the oral cavity and chronic liver disease. Eur J Oral Sci. 2000;108:378-82. |
PMid:11037753 |
8. Lazaro P, Olalquiaga J, Pico M, Longo I, García-Morrás P, Bartolomé J, et al. Detection of Hepatitis C Virus RNA and Core Protein in Keratinocytes from Patients with Cutaneous Lichen Planus and Chronic Hepatitis C. J Invest Dermatol. 2002;119:798-803. |
PMid:12406323 |
9. El Tawdy A, Rashed L. Downregulation of TLR-7 receptor in hepatic and non-hepatic patients with lichen planus. Int J Dermatol. 2012;5:785-9. |
PMid:22715821 |
10. Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7:6. |
PMid:33479224 |
11. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. |
PMid:28935701 PMCid:PMC5833365 |
12. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647. |
PMid:25555855 |
13. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-58. |
PMid:12111919 |
14. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. |
PMid:12958120 PMCid:PMC192859 |
15. Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. |
PMid:28935701 PMCid:PMC5833365 |
16. Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, et al. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level. JAMA Oncol. 2017;3:1683-91. |
PMid:28983565 PMCid:PMC5824275 |
17. Wang J, Chenivesse X, Henglein B, Bréchot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature. 1990;343:555-7. |
PMid:1967822 |
18. Nault J-C, Ningarhari M, Rebouissou S, Zucman-Rossi J. The role of telomeres and telomerase in cirrhosis and liver cancer. Nat Rev Gastroenterol Hepatol. 2019;16:544-58. |
PMid:31253940 |
19. Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents. Gastroenterology. 2017;153:996-1005. |
PMid:28642197 |
20. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-6. |
PMid:18436948 PMCid:PMC2335261 |
21. Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123-33. |
PMid:28802062 PMCid:PMC5767767 |
22. Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27-42. |
PMid:28506744 PMCid:PMC5682243 |
23. Kang T-W, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. 2011;479:547-51. |
PMid:22080947 |
24. Moeini A, Torrecilla S, Tovar V, Montironi C, Andreu-Oller C, Peix J, et al. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents. Gastroenterology. 2019;157:1383-97. |
PMid:31344396 PMCid:PMC6815707 |
25. Liu C, Wu J, Chang Z. Trends and Age-Period-Cohort Effects on the Prevalence, Incidence and Mortality of Hepatocellular Carcinoma from 2008 to 2017 in Tianjin, China. Int J Environ Res Public Health. 2021;18:6034. |
PMid:34199687 PMCid:PMC8200005 |
26. González-Moles MÁ, Ruiz-Ávila I, González-Ruiz L, Ayén Á, Gil-Montoya JA, Ramos-García P. Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis. Oral Oncol. 2019;96:121-30. |
PMid:31422203 |